News and New Releases

CoolTouch Announces 5th Annual Laser Giveaway Event at ACP Annual Meeting
ROSEVILLE, CA– coolTouch will hold their 5th Annual Laser giveaway on November 5th, 2010 in conjunction with the American college of Phlebology’s Annual Meeting being held in Orlando, Florida November 4th-7th, 2010. Join us for educational AND entertaining presentations and watch the finale of the evening as one lucky physician
wins a coolTouch branded laser with an estimated value of $70,000. You don’t want to miss this event!The event will be held directly after the exhibitor evening reception on Friday, November 5th, 2010 from 8pm-10pm
near the exhibit hall at the Renaissance Orlando Resort at SeaWorld. Register for the laser giveaway at coolTouch’s booth at the AcP Show. For more information, please visit www.CoolTouch.com.

Get Ready for IVC 2011: May 12-14
MIAMI, FL—Start making plans now for the ninth annual International Vein congress: Endovascular Venous Surgery. The meeting has just announced dates for its 2011 edition, which takes place May 12-14 on Miami Beach. Even more noteworthy, course Director Jose I. Almeida, M.D., has expanded the program to include content of value to both private and hospital-based practitioners.Already a powerhouse meeting in the world of in-office venous therapy, IVc will now give attendees even more: expert lectures, educational live cases and intriguing debates to encompass treatments for both superficial and deep disease. The new, comprehensive focus recognizes the continuing growth of endovascular surgery in office settings and likewise meets the needs of institution-based physicians who see patients with a variety of venous issues. “This is a plus for everyone,” Dr. Almeida says. “We all benefit in learning more about treatment for deep disease because it gives us a better understanding of the field. Additionally, more and more of this type of endovascular work can and will be done in private settings. This is the future.”Physicians with years of experience, those who wish to broaden the scope of their existing practices and those who want to consider moving into the venous arena are all invited and encouraged to attend IVc.“We give you everything you need to know by focusing on clinical advances, providing the lowdown on new products, presenting live cases with expert commentary and sharing tips for running a successful business,” Dr. Almeida says. “come network with your peers and visit with industry representatives in the information-packed exhibit hall.” Allied health professionals and office managers will also find informational sessions geared specifically to them.Making the meeting an even greater draw: its location at the Fontainebleau Miami Beach, one of the world’s most renowned hotels. Following the IVc sessions each day, attendees can enjoy a wide variety of activities. The Fontainebleau is located near golf and tennis, as well as lively
South Beach. For more information, go to www.IVCmiami.com.

BioMedix Provides Enhanced Diagnosis with PADnet™+ Segmental Pressures
SAINT PAUL, MN – BioMedix Vascular Solutions, Inc. today announced newly expanded testing capabilities for its award-winning vascular diagnostic system with the release of PADnet+ Segmental Pressures. The PADnet+ Segmental Pressures testing component measures blood pressure at additional levels on the legs.Non-invasive PADnet+ Segmental Pressure testing is similar to PADnet+ ABI testing, with the addition of pressures taken
at thigh and calf levels to more effectively diagnose vascular disease in the cardiovascular and Vascular Specialist office. The improved accuracy provided by Segmental Pressures aids in confirming arterial insufficiency and can help to identify inflow disease, localizing the results to specific vascular segments. PADnet+ with Segmental Pressures gives insight into the locations of possible arterial blockages in the legs, improves diagnosis and helps guide an effective P.A.D. treatment plan. For cardiovascular and Vascular Specialists, PADnet+ with Segmental Pressures, ABI, TBI and PVR tests are key to identifying and confirming obstructive or hemodynamically-significant disease to help determine whether medical or surgical intervention is necessary. Informed diagnosis increases treatment accuracy and efficiency, improving the quality of patient outcomes.
For more information about BioMedix products, call 877-854-0014 or log on to www.BioMedix.com.

Gloria Med Group of Lake Como, Italy announces their Phlebology product line available through Gloria Med USA.
PASADENA, cA – gloria Med, a worldwide leader in Phlebology products, has been manufacturing compression
stockings of superior quality since 1926. They are proud to introduce their Medical line and Support line of stockings in the United States. The Medical line of compression stockings includes: Lady gloria 24, a sheer medical stocking in 20-30 mmHg, and gloria Med stockings, including a Microfiber line, a Soft line and a comfort
line made with cotton, available in 20-30mmHg and 30-40mm Hg. Our compression stockings are manufactured at the highest standards and are offered in a variety of styles, sizes and colors. gloriaPress elastic bandages are also available. The Support line features Lady gloria 18, a sheer stocking preferred by many women worldwide, and Man‘Support, a comfortable, calf-length sock/stocking worn by discerning men. To view and evaluate gloria Med products yourself and join them in the company’s US launch celebration, please visit the company’s booth (#102) at the AcP Annual congress in Orlando, Florida.For more information, please contact Gloria Med USA at 877-390-5347, [email protected] or visit the company’s website at www.gloriamedusa.com.

Midwest Vein Center Founder Named to Chicago Magazine’s “Top Doctors” List
DOWNERS GROVE, IL – Midwest Vein center (MVc) founder, J. gordon Wright, MD, FAcS, RVT has been selected as a 2010 “Top Doctor” as listed in chicago Magazine, on newsstands now. Only 345 physicians made
the list this year and Dr. Wright was the only full time Phlebologist selected under the Vascular Surgery category.
The list, prepared for chicago by castle connolly Medical Ltd., was compiled by contacting thousands of health
professionals in metropolitan chicago and asking them to name the doctors to whom they would entrust a family
member when confronting a particular problem. The results from surveying these physicians yielded the list.
Dr. Wright is board certified in phlebology and vascular surgery and specializes in the diagnosis and treatment of
vein disease. Thirteen years ago, he founded the Midwest Vein center which has offices Downers grove, glenview
and Orland Park. Dr. Wright has been treating patients with vein problems for 25 years, since earning his medical degree from Loyola University Medical center in 1981. His fellowship in Vascular Surgery at Boston University was rewarded with the opportunity to run the Vein clinic at the Boston city hospital. He continued his career at The Ohio State University, where he started The OSU Vein clinic and trained numerous fellows, residents and other health professionals in vascular surgery, general surgery and vein disease.More information about Dr. Wright and MVC is available on the Internet at www.midwestvein.com.Sigvaris Joins Vascular Disease Foundation

LAKEWOOD, cO – The Vascular Disease Foundation (VDF) announced today that SIgVARIS, has become
a member of VDF’s National corporate Round Table. The National corporate Round Table serves to help the
foundation in its public awareness and educational efforts. SIgVARIS’s contribution will support VDF’s top priorities including activities related to the Venous Disease coalition and the continued distribution of free educational material to the general public and medical facilities. Educational materials include VDF’s quarterly magazine, Keeping in circulation, and the distribution of patient brochures on vascular diseases.“We are pleased to announce that SIgVARIS has decided to partner with the Vascular Disease Foundation,” said Anton Sidawy, MD, President of VDF’s Board of Directors. “The goal of the Foundation’s National corporate Round Table is to reduce the mortality and morbidity from vascular diseases. The Round Table is allied with the Foundation
in the belief that patient quality of life and longevity can be improved through education and prevention, prompt
diagnosis, comprehensive management and effective rehabilitation of arterial and venous disease.” Founded in 1998, VDF is the nation’s leading nonprofit information and education resource on the diagnosis and management of vascular diseases, affecting over 54 million Americans.
For more information, visit www.vdf.org or call 888-VDF-4INFO.Redesigned VascularWeb.org Launched
Chicago, IL - The Society for Vascular Surgery® (SVS)
announced the launch of its redesigned Web site, www.VascularWeb.org. The most significant upgrade is the
improved navigation. It features vascular health resources for the public, medical professionals, medical students, residents, and the media. The site receives more than three million visitors annually.The site serves as valuable background on vascular health to the media. Reporters may access current press releases on vascular
research published in SVS’ Journal of Vascular Surgery® and SVS news.Additional resources on VascularWeb.org include Patient Education Fliers, children’s Activity Book, Vascular Health Podcast Library, Find a Vascular Specialist, Find a Screening Event and Medicare Screening Benefit. Please visit www.vascularweb.org for more information. UMI to Serve as a Distributor for SonoSite Products into Private Medical Offices

BOTHELL, WA – June 22 – SonoSite, Inc. (Nasdaq: SONO), the world leader and specialist in bedside and
point-of-care ultrasound and United Medical Instruments (UMI), a worldwide provider of new and pre-owned
ultrasound systems, today announced a new agreement for UMI to distribute SonoSite’s products into certain small office markets. Under this relationship, UMI will act as

V E I N M A g A z I N E F A L L 2 0 1 0
7 6

An additional distributor of SonoSite’s flagship M-Turbo® and MicroMaxx® ultrasound systems and will serve as a
reseller of SonoSite’s used products from its older lines. This collaboration strongly positions SonoSite to continue to expand its presence in the office markets, while offering physicians greater access and customer support.SonoSite’s point-of-care ultrasound systems are designed to provide healthcare professionals with the ability to view anatomy in a greater variety of clinical settings. With the implementation of real-time visualization, physicians in office settings are able to confidently assess, diagnose and perform interventional procedures directly in the patient’s examination room.“UMI is delighted to join forces with SonoSite,” said Mansoor ghanavati, United Medical Instruments’ President and cEO. “The company has a strong reputation for creating point-of-care ultrasound products that are cutting edge and reliable and its products will fit well within our existing portfolio of high quality ultrasound solutions. We look forward to bringing more value to our customer base and we expect tremendous success in the physician offices.”Please visit www.sonosite.com or www.umiultrasound.com for
more information.

The American Board of Phlebology Opens Exam Cycle for 2011, Welcomes 2010 Class of Diplomates
RESTON, VA – October, 2010 – The American Board of Phlebology opens their fourth phlebology exam cycle
beginning October 1, 2010.Applications will be accepted between October 1 and February 11, 2011, and all are to be submitted online at http://www.abph.net/application/default.asp. The computer-based exam will be administered electronically between April 16 and April 23, 2011. Over 400 Pearson Vue testing centers will offer the test in the United States and canada during those dates.To become an ABPh diplomate, an applicant must complete the requisite training or experience qualifications, meet the continuing medical education requisites,
and pass a stringent certification examination. The initial certification period is ten years. We are proud to welcome the newest class of ABPh diplomates, who successfully completed the examination this past April. There are now 475 ABPh-certified diplomates throughout the United States and canada. Our newest diplomats will be formally welcomed by ABPh at a recognition ceremony during the American college of Phlebology Annual congress, to be held in Orlando, FL from November 4-7, 2010.More information, a content outline and a directory of certified diplomates may be found by visiting the Board’s web site, http://www.americanboardofphlebology.org,
or by calling (703) 234-4077.AngioDynamics Expands its VenaCure EVLT System to Offer Physicians Fewer Procedure Steps and a Faster Procedure Time
ALBANY, NY – AngioDynamics (NASDAQ: ANgO) announced today the launch of a new access kit allowing
ewer procedure steps and faster procedure time for physicians using the Venacure EVLT system’s NeverTouch®
gold-tip laser fiber to treat varicose veins.The new .018-inch system for the Venacure EVLT access kit reduces the number of components involved in gaining access for the procedure. The new kit provides a longer .018 inch nitinol long-access wire. The distal tip on the Trè-Sheath™ dilator is resized to accept a .018 inch nitinol access
wire, eliminating the need for a micro-access sheath, as well as the need to exchange wires during the procedure. This ultimately reduces an eight-step process to four.For more information about the VenaCure EVLT system, visit http://venacure-evlt.com.Empower Technologies Announces Completion Of Video Production On The HITECH ACT, American Recovery and Reinvestment Act of 2009 (ARRA)
SARASOTA, FL. Empower Technologies, Inc., producers of the SonoSoft® electronic health records (EHR) software suite, announced today that it has completed production of an informational video discussing the requirements of the HITEcH Act as they relate to medical professionals and medical related health record keeping.On February 17, 2009 President Obama signed into law the American Recovery and Reinvestment Act of 2009 (ARRA). Of the $787 billion invested, a large portion ($19.2 Billion) of the ARRA is allocated to improve Health Information Technology. This portion of the Act is known as the HITEcH Act. The HITEcH Act offers financial incentives to physicians who purchase, implement, and meaningfully use an Electronic Health Record (EHR) by the year 2015.This sponsored presentation was featured nationally on the Fox\Business Network™, on Saturday September 11 at 12:00 PM ET. The video is available for viewing on SonoSoft’s website: http://nomoredictation.com/aboutus; or free to medical professionals who request a copy.
Please call (800) 833-7707, or e-mail [email protected] to request a copy.
Please send your news and new product releases to [email protected] Submissions should be sent in a
Word document with an accompanying high resolution (300 dpi) image file. Editorial inclusion is at the discretion of the VEIN Magazine staff. VEIN Magazine reserves the right to edit releases for space requirements

W W W . V E I N D I R E c T O R Y . O R g / M A g A z I N E
7 7
Bauerfeind Moves to New Offices in Marietta (Atlanta), GA
MARI TTA, gA—Bauerfeind, an international leader in compression therapy and orthopedic soft goods solutions,
has moved to new offices in Marietta, conveniently located just north of Atlanta. The new location includes a spacious contemporary show room and ample space for training and customer interaction. The May move to the new office and logistics center will allow for continued expansion in the US and marks the 25 year celebration of Bauerfeind in the US. The new address is: Bauerfeind Inc., 3005 chastain Meadows Pkwy., Suite 700, Marietta, gA 30066 www.bauerfeind.com
Venous Disease Coalition Presents Research Awards to Top 3 Research Papers
LAKEWOOD, cO—The Venous Disease coalition (VDc) presented the coalition’s second annual Research
Awards to the top three research papers on venous disease published in 2009 at the organization’s Seventh Annual Meeting in Alexandria, VA. The VDc Research Awards recognize important research relevant to the understanding and/or treatment of venous disease in three categories, Basic Science, clinical outcomes and Implementation of quality improvement, or public awarenessThe VDc Research award in the category of Basic Science as presented to Peter J. Pappas, MD, Professor of Surgery and Director for New Jersey Medical
School. He and his colleagues were recognized for their work on the research study Regulation of Matrix contraction in chronic Venous Disease, published in the European Journal of Vascular Surgery (14:203-13, 2009). The study explored the role of TgF-beta(1) in venous ulcer healing and the signaling cascades regulating dermal fibroblast function.
The VDc Research Awards in the category of Research Related to Quality Improvement and Implementation of Best Practices was presented to Alpesh N. Amin, MD, Professor of Medicinefor the University of california School of Medicine. He and his colleagues were recognized for their work on the research study Inpatient thromboprophylaxis use in U.S. hospitals: Adherence to the seventh American college of chest Physician’s recommendations for at-risk medical and surgical patients published in the Journal of Hospital Medicine (2009 Oct;4(8):E15-21). This study assesses the real-world rate of appropriate inpatient VTE prophylaxis in
hospitalized U.S. medical and surgical patients at risk of VTE, in accordance with the seventh American college of chest Physicians, (AccP) guidelines.The VDc Research Award in the category of clinical Outcomes Research was presented to Russell D. Hull, MBBS, MSc, Professor of Medicine at the University of calgary. He and his colleagues were recognized for their work on the research study published in the American Journal of
Medicine (2009 Aug;122(8):762-769.e3). This study compared long-term treatment at home with tinzaparin or usual care in terms of efficacy, safety, patients’ treatment satisfaction, incidence of post-thrombotic syndrome, and associated venous leg ulcers.
Please visit www.venousdiseasecoalition.org for more information.